Methicillin and vancomycin resistant S. aureus in hospitalized patients
Open Access
- 1 January 2010
- journal article
- Published by Medknow in Journal of Global Infectious Diseases
- Vol. 2 (3), 275-283
- https://doi.org/10.4103/0974-777x.68535
Abstract
S. aureus is the major bacterial cause of skin, soft tissue and bone infections, and one of the commonest causes of healthcare-associated bacteremia. Hospital-associated methicillin-resistant S. aureus (MRSA) carriage is associated with an increased risk of infection, morbidity and mortality. Screening of high-risk patients at the time of hospital admission and decolonization has proved to be an important factor in an effort to reduce nosocomial transmission. The electronic database Pub Med was searched for all the articles on "Establishment of MRSA and the emergence of vancomycin-resistant S. aureus (VRSA)." The search included case reports, case series and reviews. All the articles were cross-referenced to search for any more available articles. A total of 88 references were obtained. The studies showed a steady increase in the number of vancomycin-intermediate and vancomycin-resistant S. aureus. Extensive use of vancomycin creates a selective pressure that favors the outgrowth of rare, vancomycin-resistant clones leading to heterogenous vancomycin intermediate S. aureus hVISA clones, and eventually, with continued exposure, to a uniform population of vancomycin-intermediate S. aureus (VISA) clones. However, the criteria for identifying hVISA strains have not been standardized, complicating any determination of their clinical significance and role in treatment failures. The spread of MRSA from the hospital to the community, coupled with the emergence of VISA and VRSA, has become major concern among healthcare providers. Infection-control measures, reliable laboratory screening for resistance, appropriate antibiotic prescribing practices and avoidance of blanket treatment can prevent long-term emergence of resistance.Keywords
This publication has 74 references indexed in Scilit:
- Vancomycin-ResistantStaphylococcus aureus,Michigan, USA, 2007Emerging Infectious Diseases, 2009
- Investigation of Reduced Susceptibility to Glycopeptides among Methicillin-Resistant Staphylococcus aureus Isolates from Patients in Ireland and Evaluation of Agar Screening Methods for Detection of Heterogeneously Glycopeptide-Intermediate S. aureusJournal of Clinical Microbiology, 2007
- Staphylococcus aureus Throat Colonization Is More Frequent than Colonization in the Anterior NaresJournal of Clinical Microbiology, 2006
- Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threatThe Lancet, 2006
- The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureusClinical Microbiology & Infection, 2006
- A 1 year surveillance study of glycopeptide-intermediate Staphylococcus aureus strains in a French hospitalJournal of Antimicrobial Chemotherapy, 2005
- Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitalsClinical Microbiology & Infection, 2005
- SHEA Guideline for Preventing Nosocomial Transmission of Multidrug-Resistant Strains ofStaphylococcus aureusandEnterococcusInfection Control & Hospital Epidemiology, 2003
- Comparison of Mortality Associated with Methicillin‐Resistant and Methicillin‐SusceptibleStaphylococcus aureusBacteremia: A Meta‐analysisClinical Infectious Diseases, 2003
- Nasal Carriage as a Source ofStaphylococcus aureusBacteremiaNew England Journal of Medicine, 2001